Theratechnologies completes 1-for-4 reverse stock split

Theratechnologies has completed the previously announced consolidation of the issued and outstanding common shares of the Company’s share capital on the basis of one post- consolidation share for each four pre-consolidation shares issued and outstanding. The Consolidation received the applicable regulatory approvals, including from the Toronto Stock Exchange and the Nasdaq Stock Market. No shareholder approval was required for the Consolidation to come into effect. The Company’s common shares began trading on the TSX and the NASDAQ on a consolidated basis on July 31, 2023.